Company / FCF Margin
Nuo Therapeutics, Inc. FCF Margin History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-131.1%
FY2015
5-year range
-230.7% / -105.0%
FY2011-FY2015
Trend
+43.2%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin returned to growth in FY2015 after 2 years of decline, reaching -131.1%.
Based on SEC 10-K filings.
-131.1% in FY2015.
Declined from -105.0% to -131.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2015, fcf margin increased 43.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | -131.1% | +43.2% |
| FY2014 | -230.7% | -119.7% |
| FY2013 | -105.0% | - |
| FY2012 | - | - |
| FY2011 | -59.4% | - |
As of FY2015 · SEC 10-K · Updated Jun 29, 2026